SRPT
Sarepta Therapeutics Inc
18.60$
-0.9%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
Sarepta Therapeutics Inc (SRPT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -5.6 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -115 | -55 | -242 | 15 | -71 | 92 | -583 | 261 | -15 | 131 | -203 | -5.6 | -92 | |
| 11 | 11 | 8.7 | 8.7 | 9.8 | 10 | 10.0 | 11 | 18 | 5.3 | 11 | 21 | 55 | |
| 48 | 46 | 41 | 50 | 43 | 50 | 41 | 37 | 15 | 30 | 29 | 54 | 128 | |
| -155 | -150 | -330 | -45 | -217 | -125 | -282 | 50 | -29 | 340 | -586 | -443 | -719 | |
| 41 | 19 | 42 | 29 | 37 | 38 | 46 | 32 | 28 | 5.8 | 3.1 | 2.6 | 40 | |
| -211 | -64 | 219 | -99 | -129 | 764 | -291 | 32 | 232 | 96 | -134 | -228 | -34 | |
| – | – | – | – | – | – | – | -25 | 0.0 | 0.0 | – | – | – | |
| – | – | – | – | – | – | -3.2 | -0.3 | -124 | -35 | 0.0 | 0.0 | -159 | |
| 15 | 1.9 | 22 | 40 | 14 | 49 | 12 | -24 | -118 | -39 | 0.2 | 0.2 | -157 | |
| -310 | -117 | -1.1 | -44 | -186 | 905 | -862 | 270 | 100 | 188 | -337 | -233 | -282 | |
| -155 | -74 | -285 | -14 | -108 | 54 | -629 | 229 | -43 | 125 | -206 | -8.2 | -131 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.